We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Understanding CIAS: What Does Current Literature Say About the Etiology and Pathophysiology of CIAS?
Martin Strassnig, MD
Philip D. Harvey, PhD
Integration Is the Key to Success: How Will the New SCZ Therapies Fit Into Clinical Treatment Paradigms?
Unraveling the Overlapping Negative and Cognitive Symptoms in Schizophrenia
Glycine's Role in Driving the Cognitive Symptoms of CIAS
Staying Current: What Do Recent Clinical Trial Data Say About the New and Emerging Treatment Options for CIAS?
Tools of the Trade: Measurement-Based Care for CIAS
Challenges of Integrating Cognitive Remediation in CIAS
CIAS Effects on Patients and Caregivers: What Is the Personal and Economic Burden Caused by CIAS?
Cognitive Impairment Associated with Schizophrenia: Pathophysiology, Diagnosis, and Emerging Treatments
Not All Therapy Needs to Be Swallowed or Injected: The Future of Digital Therapeutics to Alleviate the Negative Symptoms of Schizophrenia
Limitations of the Current Therapeutics Used to Manage CIAS
Expanding Screening, Improving Treatment Acceptance, and Optimizing Outcomes for Patients with Moderate to Severe Alcohol Use Disorder (AUD)
Annie Levesque, MD, MSc
Ethan A. Cowan, MD
Navigating the Diagnostic Maze: Strategies for Excluding MS Disease Mimics
Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
Advancements in MRI Technology: Improved Diagnosis and Monitoring of MS
Bianca Weinstock-Guttman, MD
The Complexity of Early MS Diagnosis
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education